Roxadustat Noninferior to Epoetin Alfa in Dialysis Patients
And for anemia in patients with kidney disease not undergoing dialysis, roxadustat is superior to placebo
Bariatric Surgery Up in Patients With End-Stage Kidney Disease
Complication rates similar for patients with, without ESKD undergoing laparoscopic sleeve gastrectomy
Periop Diabetic Ketoacidosis Seen in Patients on SGLT2 Inhibitors
Testing for acid load needed in patients with diabetes taking sodium-glucose cotransporter-2 inhibitors
CDC: Mortality Rates Continue to Decrease for Hispanic Adults
Difference in death rates between non-Hispanic white, Hispanic adults widened from 2000 to 2017
Senate Bill Would Reduce Drug Costs for Seniors
Bill would limit drug copays for people with Medicare Part D by capping annual out-of-pocket costs
Higher eGFR at Dialysis Initiation Tied to Lower Survival in Children
Findings seen among children with end-stage renal disease
About One in 20 Patients Exposed to Preventable Harm
Pooled prevalence of preventable patient harm was 6 percent; 12 percent was severe, led to death
Narrowing Seen in Racial/Ethnic Differences in Home Dialysis Use
Home dialysis use increased in all groups; racial, ethnic differences decreased from 2005 to 2013
Rituximab Noninferior to Cyclosporine in Membranous Nephropathy
Drug found to be superior in maintaining proteinuria remission for up to 24 months
Non-Vitamin K Oral Anticoagulants May Be Best for Early-Stage CKD
Benefit-risk profile superior to vitamin K antagonists for early-stage chronic kidney disease
